-
Uncategorized2 months agoThis week in Drug Discovery (13 – 17 April)
News round-up for 13 – 17 April by Bruno Quinney, Content Team at DDW. This week, breakthroughs have emerged in cancer research. Elsewhere, regulatory reforms have accelerated clinical trial set up in...
-
Uncategorized2 months ago
Replimune cries foul on regulatory flexibility. But many Americans want a stricter FDA
After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to exercise regulatory flexibility, while other experts...
-
Uncategorized2 months ago
Kailera raises $625M IPO in biotech record
The latest biotech IPO comes in at a record high. Kailera Therapeutics raised $625 million, topping the record set by Moderna’s public entrance. In 2018, Moderna...
-
Uncategorized2 months ago
Novartis’ Vas Narasimhan heads to Anthropic’s board; Metsera alum joins Structure as COO
→ Anthropic keeps deepening its ties to the biopharma industry, appointing Novartis CEO Vas Narasimhan to its board. The AI giant recently acquired Coefficient Bio, a...
-
Uncategorized2 months ago5 notable pharma CEO pay hikes in 2025
Several of pharma’s top leaders scored large pay bumps last year, including two new chiefs who joined the “$30 million club.” Read More
-
Uncategorized2 months agoSTAT+: Cell therapy primed liver transplant patients to avoid organ rejection, small study shows
Immune tolerance has long been the holy grail in transplant medicine, a hoped-for end to the downsides of anti-rejection regimens for patients after they receive lifesaving...
-
Uncategorized2 months agoOpinion: Don’t believe headlines saying that vaccine skepticism is widespread
Two years ago, I wrote in the New England Journal of Medicine that one of the greatest threats to childhood vaccination is the normalization of skepticism, even though...
-
Uncategorized2 months ago
Merck’s PD-1/VEGF data star in stacked lineup of AACR ‘26 data reveals
The Merck update, which will shed light on a $588 million bet to succeed Keytruda, is part of a roster of presentations that could shape the...
-
Uncategorized2 months ago
Stem Cell Editing Programs the Immune System to Make Own Therapeutic Proteins
For pathogens like HIV, malaria, and rapidly evolving influenza strains, coaxing the immune system to produce the rare, highly potent antibodies needed for protection has long...
-
Uncategorized2 months agoKailera nets $625M in one of biotech’s biggest-ever IPOs
The high-profile obesity drug developer priced the biotech sector’s biggest offering since 2022 and will use the proceeds to support a portfolio of medicines licensed from...
STAT+: Up and down the ladder: The latest comings and goings
FDA imposes import alert on Indian plant after inspectors flag GMP failings
